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and intrahepatic cholangiocyte 
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disease
Monique M. A. Verstegen1*, Floris J. M. Roos1,12, Ksenia Burka1,12, Helmuth Gehart2, 
Myrthe Jager3, Maaike de Wolf1, Marcel J. C. Bijvelds4, Hugo R. de Jonge4, 
Arif I. Ardisasmita6, Nick A. van Huizen1,7, Henk P. Roest1, Jeroen de Jonge1, 
Michael Koch5, Francesco Pampaloni5, Sabine A. Fuchs6, Imre F. Schene6, Theo M. Luider7, 
Hubert P. J. van der Doef8, Frank A. J. A. Bodewes9, Ruben H. J. de Kleine9, Bart Spee10, 
Gert‑Jan Kremers11, Hans Clevers2, Jan N. M. IJzermans1, Edwin Cuppen3 & 
Luc J. W. van der Laan1
The development, homeostasis, and repair of intrahepatic and extrahepatic bile ducts are thought 
to involve distinct mechanisms including proliferation and maturation of cholangiocyte and 
progenitor cells. This study aimed to characterize human extrahepatic cholangiocyte organoids 
(ECO) using canonical Wnt‑stimulated culture medium previously developed for intrahepatic 
cholangiocyte organoids (ICO). Paired ECO and ICO were derived from common bile duct and liver 
tissue, respectively. Characterization showed both organoid types were highly similar, though some 
differences in size and gene expression were observed. Both ECO and ICO have cholangiocyte fate 
differentiation capacity. However, unlike ICO, ECO lack the potential for differentiation towards a 
hepatocyte‑like fate. Importantly, ECO derived from a cystic fibrosis patient showed no CFTR channel 
activity but normal chloride channel and MDR1 transporter activity. In conclusion, this study shows 
that ECO and ICO have distinct lineage fate and that ECO provide a competent model to study 
extrahepatic bile duct diseases like cystic fibrosis.
Integrity of the biliary tree is imperative for liver function. Diseases that affect the bile duct integrity are com-
mon and often life-threatening. Although the adult liver is well-known for its regenerative capacity, the cellular 
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events that drive repair of the bile duct system is not fully elucidated. Mature cholangiocytes are known to have 
self-renewal capacity, both to maintain homeostasis and in response to bile duct  injury1–4. In larger bile ducts, 
including in the extrahepatic bile ducts (eBD), peribiliary glands are thought to harbor biliary stem/progenitor 
cells. Evidence suggests that these peribiliary glands provide a proliferative response upon damage of the bile 
duct providing new cholangiocytes to restore the biliary  lining5. These biliary progenitor cells have a different 
embryological origin than the bipotent progenitors found in the liver and share a common developmental origin 
with the pancreas and  duodenum6,7. This distinct developmental lineage might explain the differences in mor-
phology, function and proliferation between intra- and extrahepatic  cholangiocytes8–11.
With the development of the 3D organoid culture  technique12, epithelial cells, including those found in the 
 liver13,14 can be expanded in vitro driven by canonical Wnt-signaling. The original liver organoids were shown 
to be derived from LGR5 and EpCAM double positive cells located in the intrahepatic bile ducts (iBD), both 
for human and mouse. More recently, work from the human liver cell atlas further specified the liver organoid-
initiating cells as the TROP2 intermediate-EpCAM positive subset of cholangiocytes which share characteristics 
with biliary stem/progenitor  cells15. Therefore, the original liver  organoids14 are derived from iBD cells and should 
correctively be termed IntrahepaticCholangiocyte Organoids (ICO). However, these ICO organoids might not 
recapitulate unique features of eBD cells and might therefore not be the favorable source to be used to model 
extrahepatic biliary diseases like cholangiocyte dysfunctions, biliary strictures and atresia.
More recently, a novel culture method was published by Sampaziotis and  colleagues16, to expand primary 
cholangiocyte-like cells as organoids by stimulation of the non-canonical Wnt signaling of the planar cell polar-
ity pathway. These organoids retained many biliary characteristics in culture and apart from their application 
in disease modeling, they were used to bioengineer artificial ducts that could be successfully transplanted in 
mice. However, these non-canonical Wnt stimulated cholangiocyte organoids, unlike conventional ICO, do not 
express stem cell markers (including LGR5), but do express markers of mature cholangiocytes. In parallel with 
our studies, Rimland et al. recently showed that cholangiocyte organoids isolated from intrahepatic ducts were 
different when compared to cholangiocyte organoids derived from common bile duct, gallbladder, and pancreatic 
duct. Strikingly, they found that only a limited number of regional-specific gene markers of the tissue were con-
served in the organoids, possibly driven by the culture conditions they were subjected to Ref.17. Only expression 
of common bile duct specific gene, HOXB2, was retained in organoids derived from the common bile duct and 
not in those derived from pancreas duct or gall bladder.
The aim of this study was to establish Wnt-dependent organoids from human eBD and compare these to 
paired ICO from liver samples of the same donor. Here we report that Wnt-stimulated Extrahepatic Cholangio-
cyte Organoids (ECO) have distinct differentiation capacity towards hepatocyte-fate when compared to ICO. As 
proof of qualifying as model for eBD disease, we showcase ECO from a cystic fibrosis (CF) patient.
Results
Efficient organoid initiation from the human common bile duct. Samples from donor liver and 
the common bile duct (eBD) were dissociated and used for culture initiation (Fig. 1A). EpCAM and LGR5 fre-
quencies were determined in the cells that were isolated from eBD and liver biopsies. Flow cytometric analysis 
show that EpCAM levels were low 1.2 ± 1.6% in eBD and 0.9 ± 0.7% (average ± SD) in liver starting populations 
as anticipated and as previously  shown18. Cells isolated from ICO and ECO expressed ~ 100% EpCAM as shown 
 before14 (Supplementary Fig. S1). LGR5 expression was too low to be detected by flow cytometry (not shown). 
Organoids could be initiated from human eBD tissue with > 95% success rate from over 40 biopsies from both 
male and female organ donors or patients with a wide age range (16–70 years). On average, the first ECO were 
visible in cultures at 7 days (6.8 days ± 1.0 SD). Organoids were grown 3-dimentional in hydrogels (Matrigel) 
and after initiation organoid cultures were passaged one to two times per week (split 1:3). Organoid initiation 
efficiency and expansion potential was similar to paired ICO cultured from liver biopsies from the same donor 
(data not shown). In accordance with previous  results14, ECO could be viably frozen and thawed and in general, 
behaved similarly to ICO. Several organoid lines were biobanked early but many ECO cultures (n = 15) were 
passaged over 30 times for a period of 8 months or longer without clear signs of exhaustion. The ICO and ECO 
cultures were morphologically similar and no apparent histological differences were found (Fig. 1B–I). Both 
cultures remained proliferative at late passages (> 6 months), with 11.0 ± 2.1% and 17.3 ± 2.4% (mean ± SEM) 
Figure 1.  Culture initiation and characteristics of liver- and extrahepatic bile duct-derived organoids. 
Schematic representation of organoid culture initiation from liver biopsies (intrahepatic bile duct; iDO) and 
extrahepatic bile duct (eDO) (A). Organoids were cultured and passaged weekly (1:3 for over 30 passages/ > 8 
mo) and harvested at different passages for further analysis. ECO were cultured as efficiently as liver-derived 
ICO. Both look similar at the microscopic level (B, C), when stained with phalloidin/DAPI (D,E), and in 
FFPE sections stained by immunofluorescent KRT7 (F,G—10×) and KRT19 (H,I—10×). EdU-incorporation 
showed a similar percentage of proliferating cells (11–14% in S-phase) in both organoid types at passage 10. 
Shown is one representative result of three paired donor lines tested (J). The individual percentages are shown 
in Supplemental Fig. S2. Despite no significant difference in proliferation (p = 0.122), a significant difference 
in organoid size was found when analyzing individual organoids for 30 h (K) Shown is mean ± SEM of 100 
organoids from paired ECO and ICO of three different donors. TROP2 protein expression was found in almost 
100% of the organoid cells, both for ECO and ICO (L,M) (three paired organoid lines). Expression heatmap 
of selected genes described by Aizarani et al., as markers for liver  progenitors15. The expression levels per gene 
were collected from the normalized RNA sequencing analysis performed on four ICO and three ECO lines, and 
visualized as Z-score. Though the level of expression varied per gene, no significant difference in expression was 
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of the cells in S-phase at P10, respectively. Additional Ki67 stainings of ECO and ICO organoid sections con-
firmed this (Fig. 1J and Supplementary Fig. S2), and were similar to previously described percentages for  ICO14. 
Despite similar proliferation rates, the increase of relative organoids size as measured by time-lapse bright-field 
microscopy was significant differences for paired organoid types (Fig. 1K). Organoid size was measured starting 
3.5 days after splitting and followed for 30 h. After 12 h of measuring the size of ICO were significantly larger 
than ECO from the same donor (n = 100 organoids per type, p < 0.001). As shown in Fig. 1L, both organoid 
types express the trophoblast cell surface protein 2 (TROP2) protein which is associated with organoid-initiating 
cells) and no significant difference was found in TROP2 protein expression (Fig. 1M, 99.1% ± 1.2% in ECO and 
98.5% ± 1.0% in ICO; p = 0.67). Together, these results show that organoids are initiated efficiently from human 
eBD and iBD and have similar characteristics with only a small but significant differences in organoid size 
expansion.
Gene expression analyses of ECO and ICO. When looking at the expression of specific genes known to 
be markers for intrahepatic organoid-initiation cells identified by single cell RNA sequencing and cell  sorting15, 
all genes were present and no significant difference in expression was observed between ECO and ICO (Fig. 1N). 
These genes include epithelial cell adhesion molecule (EpCAM), leucine-rich repeat-containing G-protein cou-
pled receptor 5 (LGR5), the low-density lipoprotein receptor-related protein (LRP5/6) co-receptor  group12, 
tumor-associated calcium signal inducer 2 (TACSTD2 or TROP2), SRY-Box 9 (SOX9), Cytokeratin 19 (KRT19), 
fibroblast growth factor receptor 2 (FGFR2), transmembrane 4 L Six Family member 4 (TM4SF4) and  others15. 
Though all these markers were found positive in organoids, some genes were highly expressed (TM4SF4, KRT19) 
and some genes relatively low (LGR5 and OCT4).
Extending the gene expression analysis of specific genes associated with bi-potential progenitors, or progeni-
tors with hepatocyte-fate or cholangiocyte-fate, again as described in the human liver atlas  study15, did not show 
any significant different expressed between ICO or ECO (Fig. 2A). Looking at the global gene expression of three 
paired organoid sets and one additional non-paired ICO, revealed a high degree of similarity and only small dif-
ferences. As shown in Fig. 2B, this RNA sequencing analyses showed that only 29 genes were significantly differ-
entially expressed (p adjusted < 0.05), of which 13 were expressed at higher levels in ECO and 16 were expressed at 
higher levels in ICO. Among the genes that were more abundantly expressed in ECO were Aquaporin5 (AQP5), 
a classic water transporter-channel known to be expressed on cholangiocytes and pancreatic epithelium and to a 
lesser degree by hepatocytes, and Insulin Like Growth Factor Binding Protein 1 (IGFBP1) known to be involved 
in ductular reactions of the biliary epithelium in response to liver  damage19. Genes associated with the alcohol 
dehydrogenase pathway (ALDH1A3, AADAC) and lipid metabolism (STS), typically expressed in hepatocytes, 
are differentially expressed and upregulated in ICO. In particular ALDH1A3, highly expressed in ICO, is known 
to be involved in the biosynthesis of retinoic acid (RA) and RA signaling transduction. Interestingly, a previous 
study with lung organoids showed that inhibition of RA pathway causes an increased ALDH expression and an 
increase the size of  organoids20. Thus, higher ALDH expression in ICO may explain their larger organoid size as 
compared to ECO (Fig. 1K), however, this requires further experimental proof. Other hepatocyte-related genes 
as CYP3A4 and HNF4a were not differently expressed in ICO and ECO (Fig. 2B). The regional-specific gene for 
common bile duct tissue which was retained in common bile duct  organoids17, HOXB2, was not significantly 
different between ECO and ICO (not shown). This same study reported that PROM1, SOX9 and Albumin were 
significantly higher expressed in intrahepatic versus extrahepatic bile duct organoids. These difference was not 
confirmed in our ICO and ECO (data not shown) and may be related to the different culture conditions. Taken 
together, although these results show that gene expression in ICO and ECO was generally quite similar, several 
genes were found to be differentially expressed.
Cholangiocyte‑related ion transport activity in ECO and ICO. To execute their function to modify 
hepatocyte-derived bile, cholangiocytes harbor a number of transporter-channels on their apical membranes. 
This include the cAMP-activated CFTR channel and the  Ca2+-activated  Cl− channel CaCCs. As shown in Fig. 3, 
basolateral forskolin stimulation of ECO or ICO cells grown as a 2D monolayer, induced a short-circuit current 
(Isc). This Isc signal could be completely inhibited by the CFTR-inhibitor GlyH-101 (N-(2-naphthalenyl)-((3,5-
dibromo-2,4-dihydroxyphenyl)methylene)glycine hydrazide)21. Furthermore, apical UTP, which elicits  Ca2+ 
mobilization through activation of purinergic (P2Y) receptors, induced an lsc that was inhibited by the CaCC 
inhibitor T16inh-A01 (Fig. 3A). No differences were found in activation of the CaCC by UTP and subsequent 
inhibition by T16inh-A01. Of note, although in both organoids types clear CFTR activity was measured, the 
most pronounced response to forskolin was observed in ECO. This observation was further supported with 
another CFTR measure, the 3D forskolin-induced swelling (FIS) assay. In this FIS assay, due to changed osmo-
larity upon forskolin stimulation, water is transported inside the lumen, causing the organoids to swell. Fig-
ure 3B (ECO) and Fig. 3C (ICO) show the organoid size before and after 120 min forskolin stimulation. Both 
ECO and ICO showed swelling upon forskolin activation, demonstrating also polarization of the cells and lumi-
nal expression of the CFTR channel in the organoids. Automated quantification of the organoid-size over time 
confirmed significantly more swelling in ECO compared to ICO (Fig. 3D, p < 0.0001).
Cholangiocyte‑fate differentiation potential is similar for ECO and ICO. Different protocols have 
been developed for differentiation towards a cholangiocyte-like phenotype, both for iPSC and ICOs. As the 
starting cell population prior to differentiation already have many cholangiocyte-like properties (i.e. ion and 
water channel activities), this cholangiocyte-fate differentiation can also be considered maturation. As shown in 
Fig. 4A, after 14 days culture in differentiation medium, organoids became more dense, had thicker outer walls 
and stopped proliferating as shown in Fig. 4B, at gene expression level, stem cell and proliferation markers LGR5 
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Figure 2.  Limited differences in gene expression between ECO and ICO. Gene expression analysis of three paired ICO and ECO 
and one additional ICO line was performed using RNAseq. Selected genes, as described by Aizarani et al.15 that are expressed in 
EpCAM-positive cells and associated with progenitors, hepatocyte-fate or cholangiocyte-fate. Shown are normalized (bulk) RNA 
sequencing results of the undifferentiated ECO and ICO for this specific gene set. Expression of the progenitor, hepatocyte-fate- and 
cholangiocyte-fate associated genes was similar between ECO and ICO. The expression heatmap shows Z-scores that are color-coded 
as shown (A). No significant differences between ICO and ECO for this gene set was observed. The expression heatmap (B) indicates 
clusters of genes that are differentially expressed (29 in total, p adjusted < 0.05), 13 higher expressed in ECO and 16 higher in ICO. This 
analysis reveals that although both organoid types are very similar in gene expression profiles, there are some differences albeit in a 
relatively low number of genes.
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Figure 3.  Forskolin-induced ion channel activity is more prominent in ECO then ICO. A representative Ussing 
experiment (A) shows CFTR stimulation by forskolin (FSK, 5 μM) in ECO (blue line) and ICO (red line) 
organoids. GlyH-101 inhibits the CFTR transporter channel specifically.  Ca2+-activated Cl-channels (CaCC) 
are stimulated by UTP and inhibited by CaCC inhibitor T16inh-A01 (arrows) demonstrating the presence 
of functional CFTR and  Ca2+-activated Cl-channels in these organoids. Functionality of CFTR in 3D grown 
organoids was shown by FIS. Representative pictures of five individual calcein green-labeled ECO (B) and ICO (C) 
before (t = 0) and after (t = 120) forskolin stimulation show the swelling in time. Qualification of organoid size in 
time showed that ECO swell significantly larger upon forskolin-activation than ICO (D) (*p < 0.0001).
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and Ki76 were significantly downregulated in DM-chol both for ECO and ICO, confirming loss of stemness and 
proliferation. To benchmark the cholangiocyte-differentiated ICO and ECO, RNA expression profiles from bile 
duct tissue, published by Rimland et al.17, were used. For this, 20 genes known to be highly expressed in cholan-
giocytes were used. Gene expression clustering of ICO, ECO and the bile duct tissue showed that in both ICO 
and ECO in DM-cholangiocyte conditions, these cholangiocyte genes were upregulated (Fig. 4C).
The P-glycoprotein (Pgp) membrane transporter family member MDR1, is an apical transporter known 
to be expressed by cholangiocytes. Differentiated ECO readily took up the tracer dye and actively transported 
this to the luminal side via MDR1, resulting in a fluorescent organoid lumen (Fig. 4D). MDR1 dependency was 
confirmed by blocking luminal transport of Rh123 with the MDR1 antagonist Verapamil, resulting in accumu-
lation of dye in the cell cytoplasm. Similar results were observed for ICO in DM-chol (not shown). Finally we 
confirmed that cholangiocyte-lineage differentiation is highly dependent on Notch signaling (Fig. 4E). For this, 
a specific small molecular inhibitor of the Notch pathway, DAPT, was added during the differentiation culture 
in DM-chol. Clearly the cholangiocyte-specific genes AQP1, AE2 and HNF1b which were upregulated during 
DM-chol, were completely downregulated by treatment with DAPT. Also the Notch-related genes Notch2 and 
Jag1 were downregulated by DAPT (Fig. 4E). These results indicate that organoids initiated from both eBD and 
iBD can be driven towards a similar adult cholangiocyte-like phenotype.
Different hepatocyte‑fate differentiation potential of ECO and ICO. Previous studies demon-
strated that ICO have the potential to differentiate towards the hepatocyte  lineage14. As shown in Fig. 5, culturing 
organoids in hepatocyte differentiation medium (DM-hep) results in a clear morphological change compared to 
organoids in expansion medium (EM) in both ICO and ECO. Histological sections of the ECO and ICO grown 
in DM-hep medium for 14 days, show increasing cellular density within the individual organoids (Fig. 5A). 
Comparative gene expression analysis of EM and DM-hep of 35 genes specific for hepatocytes, cholangiocytes 
or progenitor cells selected from the human liver  atlas15 is shown in Fig. 5B. Gene expression of primary hepato-
cytes (PHH) as published by Schneeberger et al.22 were included as a benchmark for hepatocyte-fate differentia-
tion. Expression of the hepatocyte-specific genes were clearly different between ICO and ECO. In the DM-hep 
condition ECO showed less upregulation of hepatocyte-specific genes as compared to ICO, whereas progeni-
tor- and cholangiocyte-related genes were not significantly different. Of note, one of the ICO lines showed less 
prominent hepatocyte-fate differentiation but it is well known that differentiation potential varies between indi-
vidual donors.
Assessing general differences in ICO and ECO gene expression showed that undifferentiated organoids in EM 
have only limited number of significantly different genes (16 genes significantly higher in ICO and 13 in ECO, 
shown in Fig. 2B). As shown in Fig. 5C, in the DM-chol condition the difference in gene expression between 
ICO and ECO completely disappeared (1 significantly different gene). However, in the DM-hep condition clearly 
heterogeneity in gene expression profiles increased. In ECO 136 genes were significantly higher and 89 genes 
were found significantly higher in ICO (Fig. 5C), indicating a difference in response to the DM-hep condition 
between these organoid types. The expression of hepatocyte-specific genes ALB (Fig. 5D) and CYP3A4 (Fig. 5E) 
was further confirmed in 3 independent differentiation experiments and quantified by qRT-PCR. Again, though 
progenitor-related gene KRT19 was not significantly different regulated between ICO and ECO (Fig. 5F), again 
only ICO showed significant upregulation of ALB and CYP3A4 in the DM-hep condition whereas ECO clearly 
did not upregulate ALB and CYP3A4. This was also confirmed on a functional level testing CYP3A4 activity in 
an enzymatic assay (Fig. 5G). Also here, only ICO and not ECO showed a significant increase in CYP3A4 activity 
in DM-hep condition. Together these results indicate that though both ECO and ICO have similar cholangiocyte 
lineage potential (Fig. 4), only ICO and not ECO show hepatocyte lineage potential. This indicate both organoid 
types retain some regional specific differentiation potential, with the extrahepatic bile duct region lacking clear 
hepatocyte-fate differentiation.
Modelling cystic fibrosis biliary disease in ECO. To determine the feasibility to use ECO as a model 
for bile duct diseases, organoids were initiated from eBD tissue collected from a CF patient at time of liver trans-
plantation. This patient was known to carry a compound heterozygous mutation in the CFTR gene, resulting in 
a non-functional CFTR protein. Western blot analysis of protein lysate from organoids confirmed the absence of 
mature CFTR protein (band at 170 kDa) in the CF-ECO (Fig. 6A) which was clearly visible in the healthy ECO. 
Immature CFTR (band at 130 kDa) was detected in both CF and healthy organoids as expected. Initiation and 
expansion of the CF-ECO was similar efficient compared to ECO from healthy donors. As shown in Fig. 6B, EdU 
incorporation assays showed similar levels level of cell proliferation, with 18% of cells S-phase for CV-ECO, as 
compared to healthy ECO (14%, Fig. 1J). Functional transporter assays in Ussing chambers showed a clear lack 
of forskolin-activated CFTR-mediated chloride currents (Fig. 6C). To demonstrate that this non-responsiveness 
was specific for the CFTR channel, the  Ca2+ activated  Cl- channel was activated with UTP at the apical side of 
the cells. Upon UTP addition, the channel was clearly activated in the CF-ECO cells and could be specifically 
inhibited by CaCC channel inhibitor T16inh-A01. As previously showed in Fig. 3, ECO of healthy donors show 
clear activity of both CFTR and the  Ca2+ activated  Cl- channel.
The CFTR channel is known to co-localized with other transporter channels, like  MDR123. To test whether 
the CFTR deficiency in organoids effects the function of other channels we needed to differentiate CF-ECO in 
DM-chol condition in order to measure MDR1 activity. As shown in Fig. 6D, the CF-ECO showed comparable 
cholangiocyte-fate differentiation as the healthy counterparts. The morphological changes in CF-ECO appeared 
smaller. In DM-chol conditions less dense organoids were observed as compared to healthy donor ECO (Fig. 4). 
This difference could be attributed to changes in water export due to dysfunctional CFTR channel activity. As 
shown in Fig. 6E, changes in gene expression of CF-ECO in DM-chol condition were similar to normal ECO 
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(Fig. 4). Stem cell and proliferation markers, LGR5 and Ki67 were down regulated upon differentiation. Con-
versely, expression of mature cholangiocyte markers KRT19, NOTCH2, and HNF1B were upregulated (Fig. 6E). 
Although the MDR1 pump and the CFTR channel are co-localized23, MDR1 functionality was not diminished 
in ECO of CF patient (Fig. 6F). Efficient transport of the Rhodamine123 was seen in the CF-ECO which again 
could be blocked by specific inhibitor, Verapamil. Combined these results provide evidence that ECO can be 
used as a patient-specific model for bile duct diseases like CF and encourage further research on CF physiology 
and personalized drug testing.
Discussion
The development, homeostasis and repair of iBD and eBD involves distinct mechanisms, either involving chol-
angiocyte or progenitor cell proliferation or maturation. In this study, organoids were successfully initiated 
from human eBD and pair-wise compared to the well-established iBD-organoids14. Overall these two types of 
organoids, ECO and ICO, behaved highly similar in terms of gene expression, proliferation capacity and function 
capacities. Despite these similarities, we observed regional-specific differences in their differentiation potential. 
As reported earlier, ICO have clear bipotent differentiation capacity. However, here we found that ECO are com-
mitted to differentiation towards cholangiocyte-fate and lack the ability to differentiate towards a hepatocyte-like 
phenotype. A similar observation was recently reported by Rimland et al.17. They also demonstrate that differ-
ences exist between ICO and ECO which is mostly reflected in the exclusive capacity of ICO to differentiate in 
the direction of hepatocyte lineage. Considering the differences in embryonic origin ECO may also be bipotent, 
not in respect to hepatocyte-fate, but with the potential for pancreatic-lineage and cholangiocyte-lineage dif-
ferentiation potential. Although this has also been suggested by  others6,7, it requires further research to confirm 
this. As shown in Fig. 2, only few genes were differentially expressed between ECO and ICO lines. Currently, a 
follow-up study has started to find markers that distinguish between the organoid-initiating cells of each type at 
a single-cell resolution and show their localization and distribution in primary liver and bile duct tissue.
Recent advances in stem cell biology and novel culture technology enabled the large-scale expansion of pri-
mary biliary epithelium by generating complex 3D stem cell-derived constructs or organoids from liver  biopsies14. 
Whether these organoids arise from LGR5-positive or negative cells, remains to be determined. Lineage tracking 
studies in Lgr5-creERT2 reporter mice suggests that LGR5-negative cells could be activated upon liver injury 
induction and at that point start to express  LGR524. This implies plasticity of liver ductal cells that respond to 
the need of parenchymal cells.
These liver-organoids, or more specifically, ICO enabled detailed analysis of intrahepatic biliary epithelium. 
In parallel, mature cholangiocytes were derived from human induced pluripotent cells (iPSC) to act as model 
for biliary disease and drug  screening25. However, both liver-derived organoids and iPSC-based cholangiocytes 
could not provide insight into the (stem) cell populations present in eBD. With the availability of eBD biopsies 
collected during liver transplantation, we embarked on characterizing organoids from the extrahepatic biliary 
epithelium (eBD) and compared them to paired organoids initiated from iBD of the same donor. The non-
canonical Wnt-stimulated extrahepatic cholangiocyte organoids as described by  Sampaziotis16, isolated from 
eBD are potent cells for regenerative medicine  applications26,27. However, these cholangiocyte organoids are 
assumedly derived from mature primary cholangiocytes (not stem/progenitor cells) and are not dependent on 
canonical Wnt signaling like the LGR5-positive  ICO14 and ECO. Although cholangiocyte organoid cultures are 
interesting in their own right they are not representative of extrahepatic LGR5-positive stem cell populations 
which reside in the peribiliary glands and which are dependent on canonical Wnt  signaling28,29. As the ECO 
resemble biliary progenitor cells that are present in the bile ducts, they can specifically be employed in studies 
focusing on stem cell defects leading to biliary diseases and developmental biology research.
The results described in this study may reflect intrinsic differences between intra- and extrahepatic resident 
(stem/progenitor) cells. It is known that differences in phenotype and functionality between mature cholangiocyte 
populations depend on their localization along the biliary  tree17,19. With the development of novel technology as 
single cell RNA sequencing, now the cellular composition of the liver can be reconstructed based on distinct gene 
expression profiles of individual cell  types15,30. Sequencing single EpCAM-positive liver cells showed they are a 
heterogeneous set of cells including mature cholangiocytes as well as potential progenitor cell subpopulations 
which both express cell surface markers TROP2 (or TACSTD2), FGFR2, TM4SF4, and CLDN1. Further analyses 
indicated that the cell population with intermediate expression of TROP2  (EpCAM+  TROP2int) to indicate the 
true progenitor population with both hepatocyte and cholangiocyte differentiation  potential15. Interestingly, an 
Figure 4.  Both ECO and ICO have cholangiocyte-fate differentiation potential. Culturing organoids in 
cholangiocyte differentiation medium (DM-chol) for 14 days result in morphological changes, Organoids 
became more dense, had thicker outer walls as compared to EM condition and stopped proliferating (A). Shown 
are representative bright field microscopic images (bar = 1000 um). At gene expression level, stem cell and 
proliferation markers LGR5 and Ki76 were significantly downregulated in DM-chol both for ECO and ICO (B). 
Gene expression clustering is based on 20 genes selected for their high expression in cholangiocytes by single 
cell RNA sequencing. For benchmarking the cholangiocyte-differentiated ICO and ECO bile duct tissue gene 
expression profiles were used (Rimland et al.17). Both ICO and ECO showed clear upregulation of cholangiocyte 
genes in DM-chol conditions (C). Fluorescent tracer dye was used to determine transporter channel activity 
in DM-chol ECO (D) As shown in left panel, Rhodamine123 is actively transported into the lumen of ECO-
chol. This luminal transport of rhodamine was completely inhibited by MDR1 inhibitor, verapamil (10 nM, 
right panel). Blocking the Notch-pathway by DAPT, inhibit cholangiocyte-fate differentiation of ECO (E). This 
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earlier study on TROP2 in eBD reported that though TROP2 is non expressed in peribiliary glands, upon damage 
of the bile ducts TROP2 is clearly upregulated in these glands epithelial  cells31. Although novel culture techniques 
provide evidence for long-term expansion of primary  hepatocytes32,33 and primary  cholangiocytes26,27, both cell 
types remain challenging to maintain in culture while keeping their mature  functions13,14,28. Expansion of ECO 
could provide in this shortcoming. In addition to cell expansion for use in tissue engineering, as was recently 
demonstrated by recellularization of decellularized human  eBD34, we demonstrate that ECO, have the potential 
to be used as a model for bile duct-related diseases as CF. To show proof of concept, ECO were cultured from eBD 
tissue from a CF patient and assessed for disease-typical features. Transporter channels were functional in ECO 
derived from healthy donor bile duct as demonstrated by activating and blocking specific transporter function 
(CFTR and  MDR123,35), whereas CFTR channel activity was impaired in the CF patient-derived ECO. Of note, we 
also showed that healthy ECO respond significantly higher to forskolin-activation as ICO, indicating that ECO 
better mimic biliary epithelium that is affected in CF patients. Modeling diseases as CF using ECO will help to 
study not only pathways involved in fluid transport and epithelial function, but also provide the opportunity to 
test (toxic) effects of bile acids and beneficial effects of CFTR targeted drugs.
Figure 5.  ECO lack hepatocyte-fate differentiation potential. Culturing organoids in hepatocyte differentiation 
medium (DM-hep) for 14 days result in morphological changes (A). Organoids became more dense (DM-hep) 
and stopped proliferating (bar = 1000 um). H&E staining of 5 µm organoid Sections (40×) show multiple cell 
layers and dense cellular structure in DM-hep. Bulk RNA sequencing analysis was performed and 35 selected 
genes associated with heptatocyte, cholangiocyte and liver progenitor  cells15 provided an expression heatmap 
showing the relative expression of ECO and ICO organoids that were differentiated towards hepatocyte-fate 
(B). Relative gene expression levels are indicated in color, with blue for down-regulated genes and red for 
upregulated genes. None of the ECO-hep organoids clearly expressed hepatocyte-specific genes, whereas 2 of 
the 3 ICO-hep organoids showed expression towards a hepatocyte-like phenotype. Primary hepatocytes (PHH, 
adapted from Schneeberger et al.23), served as positive controls. Assessing general differences in ICO and ECO 
gene expression showed that in DM-hep condition the difference between ICO and ECO is biggest whereas 
small differences in gene expression was observed in DM-chol (C). Gene expression levels of hepatocyte-
specific genes albumin (D) and Cyp3A4 (E) were further confirmed by qRT-PCR analyses in independent 
experiments. Both albumin (D) and Cyp3A4 (E) were again found increased in ICO and not in ECO. (C). 
KRT19 (F) expression levels did not differ significantly between these organoid types. Significance is indicated 
as ***p < 0.0005. As a functional measure of hepatocyte metabolic activity, Cyp3A4 activity was measured using 
a commercially available kit (G). The relative Cyp3A4 activity was significantly higher in DM-hep conditions for 
ICO but not for ECO. Significance is indicated as *p < 0.01.
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In conclusion, this study shows the feasibility to culture Wnt-driven organoids from small tissue biopsies of 
human eBD and that these ECO can be differentiated towards functional cholangiocyte-like cells. This opens the 
avenue for use in pre-clinical toxicology studies, development and testing of novel treatments in a personalized 
setting, and tissue engineering for patient-specific clinical applications.
Material and methods
Human organoid culture initiation and expansion. Tissue samples (≤ 0.5  cm3) of donor (extrahe-
patic) common bile duct (eBD) and donor liver biopsies (n > 40) were collected during liver transplantation at 
the Erasmus Medical Center Rotterdam. Use of both tissues for research purposes was approved by the Medical 
Ethical Council of the Erasmus MC and informed consent was given (MEC-2014-060). Liver and eBD biopsies 
were obtained from a 17-year old male Cystic Fibrosis (CF) patient undergoing liver transplantation at the 
University Medical Center Groningen. Informed consent was obtained to use these biopsies for research (STEM 
Study—protocol number 1-402/K, informed consent was obtained from a parent). This patient was compound 
heterozygous for F508del and R1162X, resulting in a non-functional CFTR transporter. Biopsies were stored in 
organ preservation fluid (University of Wisconsin Belzer UW Cold Storage Solution, Bridge of Life Ltd. Lon-
don, UK) and transported at 4 °C. The biopsies were used to initiate ECO and ICO cultures which were initi-
ated as described for human liver  tissue14,36. In short, the biopsies (liver and eBD) were washed in Advanced 
DMEM/F-12 medium supplemented with penicillin/streptomycin (with 10,000 U/ml, Life Technologies), 
HEPES (1 M, Life Technologies), Ultraglutamine (200 mM, Life Technologies). Both liver and eBD biopsies 
were minced and digested in a collagenase solution (2.5 mg/ml collagenase Type A, Sigma Aldrich in Advanced 
DMEM/F-12 medium), rocking at 37 °C for 20 min. Single cell solutions were gained by passaging over a 70 μm 
nylon mesh cell strainer and washed in Advanced DMEM/F-12 medium (5 min, 1500 rpm at 4 °C) after which 
the pellet was diluted in ice cold Matrigel (Corning) and seeded in 25 μl droplets in 48-wells plates. After solidi-
fying of the Matrigel, 250 μl culture initiating medium was added and cells were incubated at 37˚C, 5% CO2 for 
three days. Culture initiating medium consisted of Advanced DMEM/F12 medium (Invitrogen) supplemented 
with 1% N2, 1% B27 (both Gibco), 1.25 mM N-Acetylcystein (Sigma), 10 nM gastrin (Sigma), 50 ng/ml EGF 
(Peprotech), 100 ng/ml FGF10 Peprotech), 25 ng/ml HGF (Peprotech), 10% R-spondin (conditioned medium), 
10 nM nicotinamide (Sigma), 5 µM A83.01 (Tocris), 10 µM forskolin (Tocris), 25 ng/ml Noggin (conditioned 
medium), 30% Wnt (conditioned medium), 10  µM Y27632 (Sigma), and hES cell cloning recovery solution 
(Stemgent). After 3 days, the initiation medium was changed to expansion medium (EM), deprived of noggin, 
Wnt, Y27632 and hES cell cloning recovery solution. Organoid formation was seen within 2 or 3 days after cul-
ture initiation and medium was refreshed every 3 days. Organoids were split (1:3) every 7 days. To prepare viably 
frozen stocks (from different passages), organoids were mechanically dissociated and mixed with recovery cell 
culture freezing medium (Gibco) according to the manufacturers protocol and stored at − 196 °C.
DNA‑synthesis and cell cycle analysis. Cell proliferation was analyzed by direct measurement of DNA 
synthesis using the Click-iT EdU Alexa Fluor 488 Flow Cytometry kit (Thermo Fisher). For this, organoids of 
different passage numbers were incubated with the thymidine analogue 5-ethynyl-2′-deoxyuridine (EdU) dur-
ing 4 h at 37 °C, 5%  CO2 after which the organoids were harvested and made single cell using trypsin–EDTA 
incubation (15 min at 37 °C). The cells were further processed according to the manufacturer’s protocol. The 
percentage of S-phase cells in the organoids was determined using standard flow cytometry methods (FACS-
Calibur, BD Biosciences).
Organoid growth rate analysis. Organoid growth rates were determined using a custom-made pipeline 
for bright field-based image segmentation (Hof et al., in submission) in three pairs of ICO and ECO (passage 
7–16). In brief, organoids were split, seeded in 5 µl of Matrigel into 96-well plates at similar densities, overlaid 
with 100 µl of expansion medium, and were cultured for 84 h before imaging. Organoids were imaged for 30 h 
at 1 h intervals using bright field microscopy (microscope: Zeiss AxioObserver.Z1; objective lens: Zeiss Plan-
Apochromat 5×/0.16; tiling: 2 × 2; z-planes: 10; z-spacing: 65 µm). The recorded time-lapse image stacks were 
pre-processed with Fiji [ImageJ version 1.51n, Java version 1.8.0_6 (64-bit)] by reducing the dimensionality 
of the raw data set from 4 (2 × 2) tiles with 10 z-planes each to 1 stitched image with 1 z-plane per time frame 
using the plugin Grid/Collection  stitching37. The resulting image stacks were subsequently segmented based on 
projected luminal areas of the organoids by using the Fiji plugin Morphological Segmentation (MorphoLibJ)38. 
Segmented luminal areas were measured with the Fiji plugin Region Morphometry (MorphoLibJ)38. The luminal 
areas of individual organoids were normalized to the average luminal area over the first 5 time-points. Organoids 
which were not detected in all 31 time frames were manually excluded from the analysis. Data is displayed as 
mean ± SEM in the corresponding graph.
Hepatocyte differentiation. Organoids were expanded for 5–7 days before initiation of hepatocyte dif-
ferentiation. Differentiation towards hepatocyte fate was initiated with the addition of 25 ng/ml BMP7 (Pep-
rotech) to the expansion medium and lasted 5 days. Subsequently, organoids were passaged with a 1:1.5 split 
ratio and medium was changed to human hepatocyte differentiation medium based on the original differentia-
tion protocol as published by Huch et al.14 and Gehart et al. (World Interlectual Property Organization Patent 
WO2017149025A1). Medium was changed every 2–3 days for a total of 10 days after which the organoids were 
analyzed for hepatocyte-specific markers.
Cholangiocyte differentiation. The protocol used to differentiate organoids towards cholangiocytes was 
adapted from the previously published protocol for iPSC differentiation towards  cholangiocytes25. From the last 
12
Vol:.(1234567890)




Scientific Reports |        (2020) 10:21900  | https://doi.org/10.1038/s41598-020-79082-8
www.nature.com/scientificreports/
steps onwards, describing the differentiation from the hepatoblast phenotype to cholangiocytes, this protocol 
was used to differentiate the eBD and iBD organoids towards cholangiocytes. In detail, organoids were expanded 
for 7 days in Matrigel to near-full wells. Culture medium was then switched to differentiation medium, con-
sisting of AdDMEM/F12 supplemented with B27 (1×, Gibco), fibroblast growth factor 10 (FGF10, 50 ng/ml, 
Peprotech), Activin-A (50 ng/ml, Gibco), and retinoic acid (3 μM, Sigma-Aldrich). After 4 days, medium was 
changed to William’s E medium (Gibco, Life Technologies) supplemented with nicotinamide (10 mM, Sigma-
Aldrich), sodium bicarbonate (17  mM, Sigma-Aldrich), 2-phospho-i-ascorbic acid tri-sodium salt (0.2  mM, 
Sigma-Aldrich), sodium pyruvate (6.3  mM, Invitrogen), glucose (14  mM, Sigma-Aldrich), HEPES (20  mM, 
Invitrogen), ITS + premix (BD Biosciences), dexamethasone (0.1 M, R&D Systems), epidermal growth factor 
(EGF, 20 ng/ml, R&D Systems), Ultraglutamine (2 mM, Invitrogen), and penicillin (100 U/ml)/ streptomycin 
(100 g/ml). Differentiation was blocked by adding 50 μM DAPT (Sigma) to the culture medium. The medium 
was refreshed every 2 days for a total of 10 days after which the organoids were analyzed.
RNA sequencing. Organoids (ICO and ECO, before and after differentiation towards the hepatocyte and 
cholangiocyte phenotypes) were collected in lysis buffer (QIAzol lysing reagent, Qiagen) and total RNA was col-
lected using the miRNeasy mini kit (Qiagen). The amount and integrity of RNA was analyzed using the Agilent 
2100 Bioanalyser (Agilent). RNA sequencing libraries were generated from 100 ng of total RNA using the TruSeq 
Stranded Total RNA Library Prep Human/Mouse/Rat kit (Illumina) and sequenced 2 × 75 bp on the Illumina 
Nextseq500. Sequencing reads were subsequently aligned against the human reference genome (GRCh37) using 
STAR 2.4.2a 21and counted with HTSeq 0.6.1 22. Differential expression analysis was done using DESeq 1.20.0 
23. Genes were considered to be significantly differentially expressed when p adjusted < 0.05 (Benjamini Hoch-
berg FDR correction). RNA sequencing data was submitted to EGA under study ID: EGAS00001003792. To 
access: Username: reviewer22677@ebi.ac.uk, password: unYGgKju. The GSEA analysis was performed using the 
software from Broad Institute (v4.0.3).
Forskolin‑indiced swelling assay (FIS). To assess CFTR functionality, Forskolin-Induced Swelling (FIS) 
of organoids was performed essentially as described by Dekkers et al.39,40. In brief, ICO and ECO were seeded in 
96-well cell culture plates (circa 50/well), in a 5 µL droplet of Matrigel. After 2 days, organoids were loaded with 
calcein-green (Invitrogen; acetoxymethyl ester; 5 µmol/l; 1 h) suspended in modified Meyler solution. Calcein-
fluorescent, viable organoids were maintained at 37 °C in 5%  CO2, and visualized on a confocal microscope 
equipped with a computer-controlled moveable stage (5× objective; Leica TCS SP5). After CFTR phosphoryla-
tion/activation was triggered by addition of forskolin (5 µM), images were acquired at 6 min intervals for 2 h. 
CFTR-mediated anion secretion stimulates osmotic fluid transport into the enclosed organoid lumen, leading 
to a volume increase. To assess organoid swelling, the area enclosed by the fluorescent cells lining the organoids 
was quantified on the ImageJ platform (NIH, USA), using a software module developed by the Optical Imaging 
Center of the Erasmus MC, which fully automates image analysis. Data depict the cumulative increase in volume 
over 1 h. In the graphic display of the data, each data point represents the average of triplicate wells.
Ussing chamber assay. Ussing chamber assays were performed essentially as described  elsewhere41. In 
short, organoids were dissociated into single cells and seeded on a permeable support (Transwell 3470; Corning) 
that were coated with Matrigel (1:20 in PBS), and cultured in EM organoid medium. After the cells had formed 
a confluent monolayer (circa 10 days after seeding), filters were inserted in Ussing chambers (P2302T/P2300; 
Physiologic Instruments, San Diego, CA), and bathed in modified Meyler solution (128 mM NaCl, 4.7 mM KCl, 
1.3 mM  CaCl2, 1.0 mM  MgCl2, 0.3 mM  Na2HPO4, 0.4 mM  NaH2PO4, 20 mmol/l  NaHCO3, 10 mM HEPES), 
supplemented with glucose (10 mM), in 95%  O2, 5%  CO2, pH 7.3, at 37 °C. The transepithelial potential differ-
ence (PD) was clamped at 0 mV using a VCC MC8 voltage clamp module (Physiologic Instruments), and the 
resulting short-circuit current (Isc) was digitally recorded using an analog-to-digital signal converter and associ-
Figure 6.  Patient-derived ECO can model cystic fibrosis biliary disease. ECO cultures were initiated from CF 
patient extrahepatic bile duct tissue. ECO from healthy donors were used as positive controls. Western blot 
analysis showed clear expression of wild type mature CFTR protein (170 kDa) in healthy control ECO, whereas 
this protein was absent in CF-ECO (A). Instead, only an immature CFTR (band of 130 kDa) was present in 
CF-ECO.The immature band was also detected in healthy ECO organoids and in a T84 control cell line (colon 
carcinoma cell line expressing mature CFTR). Shown is a cropped blot and b-actin served as a loading control. 
The full blot is provided in the supplemental information file. The CF-ECO showed similar cell proliferate 
speed as healthy ECO; 18% at passage 15 as demonstrated with EdU incorporation using flow cytometry (B). 
Functional transporter assays were done using CF-ECO (blue line) and healthy ECO (pink line) in an Ussing 
chamber assay (C). As expected, CF-ECO cells do not respond to CFTR stimulation with forskolin, whereas 
healthy ECO stimulated with forskolin showed a clear current which was inhibited by CFTR inhibitors, GlyH-
101 and pyrimido-pyrrolo-quinoxalinedione (PPQ). These inhibitors had no effect on the CF-ECO. Stimulation 
with UTP shows functionality of other  Ca2+-dependent  Cl- channels in both ECO (CF and healthy) and both are 
responsive to the specific inhibitor of this channel, T16A-inh-A01. Representative cultures of undifferentiated 
CF-ECO (upper panel, D) and CF-ECO that are differentiated towards cholangiocytes (DM-chol, lower panel, 
D). Changes in gene expression of CF-ECO after cholangiocyte-fate differention (E). Changes are similar 
to healthy ECO. Functional transport of Rhodamine123 via transported channels was shown in CF-ECO 
organoids differentiated towards cholangiocyte fate (F). This signal is specific for MDR1 as it could be complete 
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ated software (Acquire and Analyze 2.3; Physiologic Instruments). Anion secretion was stimulated by addition 
of the adenylyl cyclase activator forskolin (10 µmol/l, Sigma-Aldrich) or the purinergic receptor agonist UTP 
(50 µmol/l, Sigma-Aldrich) to the luminal bathing solution. Forskolin-induced and UTP-induced secretion was 
inhibited by Glyh-101 (20 µmol/l, Sigma-Aldrich) and T16inh-A01 (50 µmol/l, Sigma-Aldrich), respectively.
Rhodamine 123 assay. To determine the presence of calcium channels, including multidrug resistance 
protein 1B (MDR1b—important in the biliary excretion of large hydrophobic components—member of the 
P-glycoprotein membrane transporter family), Rhodamine 123 (Rh123) was added to the cultures. Rh123 
is a fluorescent chemical compound that can be transported by these transporter channels 27. For this, cold 
Advanced DMEM/F12 medium was used to remove Matrigel and collagen from the cultures that were subse-
quently pretreated with DMSO or 10 μM Verapamil (Sigma-Aldrich—MDR1b inhibitor) for 30 min, followed 
by 5 min of incubation with 100 μM Rh123 (Sigma-Aldrich). The organoids were washed 3 times with expan-
sion medium. Fluorescence (excitation wavelength: 511 nm; emission wavelength: 534 nm) was visualized with 
a Leica SPE-II confocal system, 30 min after washing and analyzed with ImageJ.
Flow cytometry. To assess TROP2 expression, paired ICO and ECO (passage 5) from three donors were dis-
sociated using Trypsin/EDTA (15 min at 37 °C), washed in 8 ml in Advanced DMEM/F-12 medium (1500 rpm, 
5 min, 4 °C) and cells were re-suspended in EBSS to make a single cell suspension. TROP2 antibody (Invitrogen; 
rabbit monoclonal conjugated to Alexa Fluor-488, clone MR54, used 1:100) was added (30 min, on ice) and cells 
were subsequently measured on a FACS Canto flow cytometer (BD Biosciences).
Flow cytometric analysis of the starting cell populations, liver (n = 3) and extrahepatic bile duct biopsies 
(n = 3), collected during liver transplantation were treated similar to organoid initiation as described above. 
Instead of addingMatrigel to initiate the organoid cultures, the cells were stained for flow cytometry using 
monoclonal antibodies against human LGR5 (1:100, Clone 8F2, BD Biosciences) and human EpCAM (1:100, 
Clone 9C4. Biolegend), conjugated directly with PerCP and PerCP/Cy5.5, respectively. Cells were measured on 
a FACS CantoII flow cytometer (BD Biosciences) and analysed using FACS Diva software. Cells from ICO and 
ECO were harvested by trypsin-treatment (10 min, 37 °C), subsequently washed in Advanded DMEM/F-12 and 
stained with EpCAM and LGR5 to be analysed by flow cytometry.
Immunohistochemistry. Organoids were formalin-fixed (4%) for 24 h, paraffin-embedded and sectioned 
(5 µm) for histological examination. To analyze the general morphology, sections were stained with hematoxy-
lin–eosin (H&E) and analyzed using a bright field microscope. Additional sections were processed and stained 
using standard IHC protocols with specific antibodies for cytokeratin 19 (KRT19) and Mucin-1 (Muc-1). After 
deparaffinization, antigen retrieval was performed in a citrate buffer (pH 6) at boiling temperatures for 10 min. 
Subsequently, sections were incubated with primary antibodies (Muc-1 clone E29, Fisher Scientific 1:500, and 
KRT-19 clone RCK108, Agilent Dako, 1:250) overnight at 4 °C. After washing, sections were incubated with 
secondary antibody (Envision Flex HRP, Agilent) for 60 min at RT prior to incubation with DAB substrate. 
Slides were analyzed with a bright field microscope and imaged with a Nikon DS camera. To determine cell pro-
liferation, stainings were done on sections using standard immunofluorescence (IF) protocols, using a specific 
antibody for Ki67 (1:100, kind gift from PARTS, Department of Pathology, Erasmus MC, Rotterdam), CFTR 
Western blot analysis.
To demonstrate the near absence of the CFTR protein in the CF-eBD organoids, Western blot analysis was 
performed. Cells from ECO derived from CF patients and healthy donors were harvested, collected by centrifu-
gation, and lysed in ice-cold RIPA buffer (Cell Signaling Technology) supplemented with a protease inhibitor 
cocktail (Roche). Total protein content was measured photometrically using the RC-DC protein assay (Bio-Rad 
Laboratories, Inc., CA). Cell lysates were subjected to sodium dodecylsulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) (8.0% acryl amide), and proteins were transferred to polyvinylidene fluoride membrane (120 V, 
70 min). Nonspecific binding sites were blocked for with Western blot blocking buffer (1 h, RT; ThermoFisher 
Scientific). The CFTR primary antibodies ‘570’ and ‘596’ antibodies were obtained through the Cystic Fibrosis 
Foundation Therapeutics initiative (www.cftrf oldin g.org/CFFTR eagen ts.htm) and used at a 1:400 dilution in 
Western blot blocking buffer (16 h, at 4 °C)39,42. After washing in Tris-buffered saline with Tween-20 (TBST), 
the membrane was incubated with donkey polyclonal anti-mouse immunoglobulin (Ig)G-H&L HRP (Abcam, 
1:10.000; 1 h) in Western blot blocking buffer. After washing, the reaction was visualized using Chemilumines-
cence (ChemiDoc, Bio-Rad). Normalization was done to ß-actin (C4 HRP, sc-47778, Santa Cruz Biotechnology, 
USA) expression using Image Studio lite version 5.2 (LI-COR Biosciences, NE).
Statistical analysis and data access. All values are represented as mean ± SEM. All statistical analysis 
were performed using GraphPad Prism 7, R statistical environment or Python 3 with NumPy, Pandas and SciPy 
libraries 28. A two-sided Student’s t-test was done to test statistical significance between means (qRT-PCR) and 
Two-tailed t-test was performed to analyse relative ICO and ECO sizes. A p value < 0.05 was considered statisti-
cally significant. RNA sequencing data was submitted to EGA under study ID: EGAS00001003792.
All methods were carried out in accordance with relevant guidelines and regulations of the Erasmus MC—
University Medical Center Rotterdam and The Netherlands.
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